Article Information
History
- March 8, 2023.
Article Versions
- You are currently viewing Version 1 of this article (March 8, 2023 - 14:42).
- Version 2 (October 19, 2023 - 15:01).
- View Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- E Stener-Victorin1,
- G Eriksson1,
- M Mohan Shresta2,
- C Perian2,
- B Jude1,
- V Engman1,
- R Boi2,
- E Nilsson3,
- C Ling3,
- J Nyström2,
- I Wernstedt Asterholm2,
- J T Lanner1 and
- A Benrick2,4,*
- 1Department of Physiology and Pharmacology, Karolinska Institute, 17177 Stockholm, Sweden
- 2Department of Physiology, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, 40530 Gothenburg, Sweden
- 3Epigenetics and Diabetes Unit, Department of Clinical Sciences, Lund University Diabetes Centre, Lund University, Malmö, Sweden
- 4School of Health Sciences, University of Skövde, 54128 Skövde, Sweden
- ↵*Corresponding author Anna Benrick, University of Gothenburg, Institute of Neuroscience and Physiology, Department of Physiology, Box 432, 405 30 Gothenburg, Sweden, Phone: +46 (0)709490148, E-mail: anna.benrick{at}gu.se